You have 9 free searches left this month | for more free features.

bioresorbable vascular scaffold stents

Showing 1 - 25 of 8,358

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,

Completed
  • Coronary Artery Disease
  • Implantation of everolimus-eluting bioresorbable vascular scaffold stent
  • +2 more
  • Fribourg, Switzerland
    Fribourg Cantonal Hospital
Oct 14, 2021

Bioresorbable Vascular Scaffold in Routine Clinical Practice

Active, not recruiting
  • Arterial Occlusive Diseases
  • +3 more
  • Bioresorbable Vascular Scaffold
  • Seoul, Songpa-gu, Korea, Republic of
  • +13 more
Dec 11, 2022

Critical Limb Ischemia Trial in Saint Helena, Leipzig (MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal

Recruiting
  • Critical Limb Ischemia
  • MOTIV Sirolimus-Eluting Bioresorbable Scaffold
  • Percutaneous Transluminal Angioplasty (PTA) Device
  • Saint Helena, California
  • +1 more
Oct 19, 2022

Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))

Not yet recruiting
  • Coronary Artery Disease
  • MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
  • (no location specified)
Jun 10, 2022

Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS), Abbott Vascular

Recruiting
  • Coronary Artery Disease
  • Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
  • Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
  • Kunming, China
    Fuwai Yunnan Cardiovascular Hospital
Mar 16, 2022

IRIS-BVS AMI Registry

Terminated
  • Arterial Occlusive Diseases
  • +2 more
  • Bioresorbable Vascular Scaffold
  • Seoul, Korea, Republic of
    Asan Medical Center
Sep 6, 2021

Coronary Artery Stenosis Trial in Austria, Germany (ABSORB Scaffold)

Completed
  • Coronary Artery Stenosis
  • ABSORB Scaffold
  • Vienna, Wien, Austria
  • +80 more
Mar 31, 2022

Cardiac Allograft Vasculopathy Trial in Italy, Netherlands (Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB))

Completed
  • Cardiac Allograft Vasculopathy
  • Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
  • Cagliari, Italy
  • +9 more
Sep 29, 2021

Peripheral Arterial Disease, Critical Limb Ischemia Trial in Austria, Germany (MOTIV BVS)

Active, not recruiting
  • Peripheral Arterial Disease
  • Critical Limb Ischemia
  • MOTIV BVS
  • Vienna, Austria
  • +7 more
Aug 30, 2021

Coronary Artery Disease Trial in Luebeck (Everolimus-eluting bioresorbable vascular scaffold, Everolimus-eluting stent)

Terminated
  • Coronary Artery Disease
  • Everolimus-eluting bioresorbable vascular scaffold
  • Everolimus-eluting stent
  • Luebeck, Germany
    University of Luebeck
Sep 24, 2019

Acute Coronary Syndrome Trial in Toulouse (SYNERGY stent, ABSORB (Everolimus-eluting Bioresorbable Vascular Scaffold))

Completed
  • Acute Coronary Syndrome
  • SYNERGY stent
  • ABSORB (Everolimus-eluting Bioresorbable Vascular Scaffold)
  • Toulouse, France
    Didier CARRIE
Aug 19, 2019

Coronary Artery Disease Trial in Denmark, Latvia (Absorb, Desolve)

Active, not recruiting
  • Coronary Artery Disease
  • Absorb
  • Desolve
  • Aarhus N, Denmark
  • +3 more
Jan 5, 2021

Critical Limb Ischemia Trial in Singapore (BVS, Abbott Vascular)

Completed
  • Critical Limb Ischemia
  • BVS, Abbott Vascular
  • Singapore, Singapore
    Changi General Hospital
Oct 6, 2020

Coronary Occlusion Trial in Bern (OCT-guided PCI, Angiography-guided PCI)

Terminated
  • Coronary Occlusion
  • OCT-guided PCI
  • Angiography-guided PCI
  • Bern, Switzerland
    Inselspital Bern
Feb 23, 2022

Coronary Artery Disease, Stable Angina, Coronary Artery Stenosis Trial in Odense (ScoreFlex balloon, Device: standard

Recruiting
  • Coronary Artery Disease
  • +9 more
  • ScoreFlex balloon
  • Device: standard non-compliant balloon
  • Odense, Denmark
    Odense University Hospital
Nov 30, 2021

Intracoronary Angioplasty Trial in Rouen

Completed
  • Intracoronary Angioplasty
    • Rouen, France
      Clinique Saint Hilaire
    Sep 20, 2022

    First, Second, and New Drug-Eluting Stents in Routine Clinical

    Recruiting
    • Coronary Artery Disease
    • Percutaneous Transluminal Coronary Angioplasty
      • Multiple Locations, Korea, Republic of
        Korean centres
      Jul 14, 2022

      Patients Treated With Bioresorbable Vascular Scaffolds

      Withdrawn
      • Coronary Artery Disease
      • Bioresorbable Vascular Scaffold
      • Drug Eluting Stent
      • Falls Church, Virginia
        Inova Fairfax Hospital
      Jun 12, 2020

      Coronary Artery Disease, Ischemic Heart Disease, Stable Angina Trial in Ulm (use of bioresorbable vascular scaffolds)

      Completed
      • Coronary Artery Disease
      • +4 more
      • use of bioresorbable vascular scaffolds
      • Ulm, Germany
        University of Ulm
      Apr 25, 2020

      Chronic Limb-Threatening Ischemia Trial (MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal

      Not yet recruiting
      • Chronic Limb-Threatening Ischemia
      • MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
      • Percutaneous Transluminal Angioplasty (PTA)
      • (no location specified)
      Oct 9, 2023

      Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Worldwide (Absorb BVS, XIENCE)

      Completed
      • Coronary Artery Disease
      • +3 more
      • Absorb BVS
      • XIENCE
      • Birmingham, Alabama
      • +119 more
      Jul 8, 2022

      Myocardial Infarction, Coronary Artery Disease Trial in Odense (OCT guided PCI, Angiography guided PCI)

      Active, not recruiting
      • Myocardial Infarction
      • Coronary Artery Disease
      • OCT guided PCI
      • Angiography guided PCI
      • Odense, Region Of Southern Denmark, Denmark
        Odense University Hospital
      Feb 28, 2021

      Critical Limb-Threatening Ischemia, Critical Limb Ischemia, Critical Lower Limb Ischemia Trial (MAGNITUDE BRS)

      Not yet recruiting
      • Critical Limb-Threatening Ischemia
      • +2 more
      • MAGNITUDE BRS
      • (no location specified)
      Oct 4, 2023

      Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System)

      Recruiting
      • Coronary Artery Disease
      • Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
      • Kunming, Yunnan, China
        Fuwai Yunnan Cardiovascular Hospital
      Mar 16, 2022

      Autoimmune Diseases, Coronary Artery Disease Trial in Budapest (Percutaneous coronary intervention with new generation fully

      Completed
      • Autoimmune Diseases
      • Coronary Artery Disease
      • Percutaneous coronary intervention with new generation fully resorbable scaffold
      • Budapest, Hungary
        Semmelweis University Heart and Vascular Center
      Apr 22, 2021